$AMD

This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Advanced Micro Devices (NASDAQ:AMD)

Analysts upgraded five companies: UBS raised Fluence Energy's (FLNC) target to $12, Morgan Stanley boosted Dynatrace's (DT) target to $65, Raymond James upgraded AMD (AMD) to Strong Buy with a $641 target, Bernstein increased Summit Therapeutics' (SMMT) target to $11.9, and Wells Fargo raised Shift4 Payments' (FOUR) target to $59.

Original reporting
Published Aug 25, 2026, 1:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 2:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$AMD
Bullish
high confidence
Mentioned
$AMD · $FLNC · $DT · $SMMT · $FOUR
Relevance
5/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$AMDBullishMed
01

Why it matters

Collective upgrades signal a generally positive bias from sell-side analysts, potentially prompting short-term buying pressure.

02

Market read

Upgrades across multiple stocks may create sector momentum, especially in tech and payments.

03

What to watch

Potential macro headwinds could dampen the impact of these upgrades.

Relevance 5/10Novelty 6/10Timing: same-day upgrade

Background

The article aggregates recent analyst rating upgrades for several U.S.-listed companies.

Company-level read

Ticker impact

$AMDBullishHigh confidence
Context

Raymond James upgraded AMD to Strong Buy with a new price target of $641.

Expected impact

Potential short-term upside as analysts raise target.

Evidence & confidence

Strong Buy rating and higher target suggest improved outlook.

$FLNCNeutralMedium confidence
Context

UBS upgraded Fluence Energy to Neutral and raised target to $12.

Expected impact

Limited upside unless further catalysts emerge.

Evidence & confidence

Upgrade is modest; price target modestly higher than current price.

$DTBullishMedium confidence
Context

Morgan Stanley upgraded Dynatrace to Overweight with target $65.

Expected impact

Likely modest rally toward new target.

Evidence & confidence

Higher weight and target indicate confidence in growth.

$SMMTBullishLow confidence
Context

Bernstein upgraded Summit Therapeutics to Market Perform, target $11.9.

Expected impact

Potential incremental gain.

Evidence & confidence

Small target increase; biotech remains volatile.

$FOURBullishMedium confidence
Context

Wells Fargo upgraded Shift4 Payments to Overweight, target $59.

Expected impact

Possible short-term rally.

Evidence & confidence

Higher weight and target suggest better outlook.

Market effects

Analyst upgrades may lift sentiment across the technology and payments sectors.

U.S. equity markets could see modest gains in related stocks.

Limited to U.S.-listed companies; minimal global effect.

Counterpoint

Upgrades may be premature if underlying fundamentals remain weak.

Key entities

  • Raymond James

    Provided AMD upgrade.

  • UBS

    Provided Fluence Energy upgrade.

Related articles

$FLNCMed

Wall St rises as lower oil prices offset Fed rate hike

US stock indices rose on Thursday as lower oil prices offset the Fed's rate hike, with the S&P 500 up 0.94%. Tech shares like Nvidia and Amazon gained 2%. The Fed signaled more hikes may be needed, causing volatility. Crypto-linked stocks like Robinhood and Coinbase also rose. Fluence Energy fell 16% after lowering its 2026 revenue forecast.

$FLNCHighAI 8/10

Why Fluence Energy (FLNC) Stock Is Nosediving

Fluence Energy (FLNC) shares dropped 13.9% after lowering its 2026 revenue guidance to $2.4B from $3.0B due to U.S. supply chain issues. Analysts cut price targets following the announcement. The stock is down 66.3% YTD and trades 76% below its 52-week high.

$FLNCHighAI 8/10

Fluence Energy shares drop after Houston delays prompt cuts

Fluence Energy (FLNC) shares dropped 14% after revising its 2026 revenue outlook to $2.4B from $3B and increasing its adjusted EBITDA loss to $200M. CEO Julian Nebreda cited delays in Houston facility ramp-up. The company is restructuring and appointed Bernerd Da Santos as COO. CFO Ahmed Pasha aims for positive cash flow.